Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Canada to create...

    Canada to create national drug agency to cut cost of prescription medicines

    Farhat NasimWritten by Farhat Nasim Published On 2019-03-21T09:30:49+05:30  |  Updated On 21 March 2019 9:30 AM IST
    Canada to create national drug agency to cut cost of prescription medicines

    Branded medicines cost, on average, 20 per cent more in Canada than in other advanced economies, and around 20 per cent of Canadians are uninsured or underinsured, Ottawa says.


    OTTAWA: Canada will create a national drug agency to help cut the cost of prescription medications as part of a plan to broaden the state-funded healthcare program, the finance ministry said in its budget on Tuesday.


    Unlike other countries with universal healthcare, Canada does not cover prescription drugs, leaving most Canadians to rely on a mixture of public and private insurance plans.


    Prescription drug spending in Canada has jumped to C$33.7 billion ($25.3 billion) in 2018 from C$2.6 billion in 1985 and a promise to boost drug coverage is set to be a major plank for the ruling Liberals in an election this October.


    Branded medicines cost, on average, 20 per cent more in Canada than in other advanced economies, and around 20 per cent of Canadians are uninsured or underinsured, Ottawa says.


    The new Canada Drug Agency would "take a coordinated approach to assess the effectiveness and negotiating prescription drug prices," which could help lower the cost of medications by up to C$3 billion a year in the long term, the budget said.


    The agency - which is not scheduled to start work until the 2022-23 fiscal year - would assess the effectiveness of new drugs, negotiate prices and recommend which medications represented the best value for money.


    "These measures alone will not fully close the gap for people who need prescription drugs and can't afford them. But they do mark important first steps on the way to a system that helps all Canadians get the medicine they need," Finance Minister Bill Morneau said in his budget speech.


    Innovative Medicines Canada, the main lobby group for patented drugmakers, said it would welcome any move to streamline what it called a very complex drug regulatory process, but added it was not clear where the government planned to make the C$3 billion in annual savings.


    "The industry is very aware of the sustainability issue on drug costs. ... I think there will be some very good conversations coming up in the next few weeks and months," the group's president, Pamela Fralick, said by phone.


    Ottawa will also create a national strategy to improve access to high-cost drugs for rare diseases, investing up to C$1 billion over two years starting in the 2022-23 fiscal year.


    SCOPE FOR NEGOTIATIONS


    The Canadian Life and Health Insurance Association said it was cautiously optimistic about the measures.


    "We believe it leaves scope there for them to be negotiating on behalf of all Canadians, which includes private and public payers," Chief Executive Officer Stephen Frank said by phone, adding he was not too concerned by how long it would take to set up the agency.


    "There's no way to snap your fingers and cut the price of drugs," he said.


    Reuters reported in late January that the government was set to unveil a limited expansion to the healthcare system to help cover the cost of drugs.


    A senior government official, who requested anonymity given the sensitivity of the situation, said the Liberals would disclose more plans for dealing with high-drug costs during the election campaign.


    Those plans would depend in part on the final report of a Canadian advisory council studying prescription drug coverage, which is due in August, added the official.


    Also Read: Novartis faces shareholder criticism over drug prices at annual general meeting

    Bill MorneauCanadaCanada Drug AgencyFinancehealthHealth Insurance AssociationHealthcareInnovative Medicines CanadamedicalmedicationsmedicinemedicinesMinistry of Financenational drug agencyOTTAWAPamela Fralickpharmapharma newspharma news indiaprescription drugrare diseasesStephen FrankUniversal Healthcare
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok